Our Companies
We focus on sectors that have strong decades-long tailwinds, where we have direct experience and where we can leverage our strong external networks to create value
Information Technology
-
High Performance
Semiconductors -
Cellular
Infrastructure -
Storage
Infrastructure -
Data Analytics / Artificial Intelligence
-
Internet of Things (IoT)
Life Sciences
Therapeutics and medical devices across the following clinical indications:
-
Cardiovascular
-
Oncology
-
Respiratory
Diseases -
Infectious
Diseases -
Dermatology
-
Autoimmune
![](https://www.newscienceventures.com/wp-content/uploads/2021/04/ABL-Logo-300x84.png)
ABL Space Systems
Develops low-cost launch vehicles for the small satellite industry.
View Website![](https://www.newscienceventures.com/wp-content/uploads/2020/11/Logo_Achronix.jpg)
Achronix Semiconductor Corporation
Supplier of embedded field programmable gate array (eFPGA) technology.
View Website![](https://www.newscienceventures.com/wp-content/uploads/2020/11/akarna_blue_org_mag_resized37.jpeg)
Akarna Therapeutics
Acquired by Allergan. Focused on the development of a small molecule therapy for the treatment of NASH.
![](https://www.newscienceventures.com/wp-content/uploads/2023/05/Analog-Inference_logo_horizontal_gradient-300x33.jpeg)
Analog Inference
Providing the highest AI performance at the industry's lowest power.
View Website![](https://www.newscienceventures.com/wp-content/uploads/2022/06/Antevia_Horizontal_Color_Large-300x59.webp)
Antevia Networks
High performance 4G & 5G coverage designed specifically for enterprise.
View Website![](https://www.newscienceventures.com/wp-content/uploads/2022/06/Avari_Wireless_Blue_Small.webp)
Avari Wireless
Manufactures public safety Digital Distributed Antenna Systems for Emergency Responder Radio Communications Systems.
View Website![](https://www.newscienceventures.com/wp-content/uploads/2017/10/Biomodal_2C@4x-300x89.png)
Biomodal
Focused on the development of tools for epigenetic analysis.
View Website![](https://www.newscienceventures.com/wp-content/uploads/2020/11/biovexwhite.png)
Biovex
Acquired by Amgen. Focused on the development of an oncolytic vaccine for melanoma and head and neck cancer.
![](https://www.newscienceventures.com/wp-content/uploads/2020/11/Logo_Caringo.jpg)
Caringo, Inc.
Focused on changing the economics of content storage and managing data through software designed object storage.
View Website![](https://www.newscienceventures.com/wp-content/uploads/2020/11/ceptionwhite.png)
Ception
Acquired by Cephalon. Focused on the development of a biologic therapy for the treatment of asthma.
![](https://www.newscienceventures.com/wp-content/uploads/2020/11/conorwhite.png)
Conor Medsystems
Acquired by Johnson & Johnson. Focused on the development of drug-eluting stents to treat coronary artery disease.
![](https://www.newscienceventures.com/wp-content/uploads/2020/11/Logo_Dali.jpg)
Dali Wireless, Inc.
Creator of a platform to provide mobile data service coverage that is scalable to the growth of mobile data demand.
View Website![](https://www.newscienceventures.com/wp-content/uploads/2020/11/dezimawhite.png)
Dezima
Acquired by Amgen. Focused on the development of a small molecule therapy for dyslipidemia.
![](https://www.newscienceventures.com/wp-content/uploads/2020/11/DUSTIdentity-1-300x144.png)
DUST Identity
Utilizes diamond crystals to enable secure identification of physical objects.
View Website![](https://www.newscienceventures.com/wp-content/uploads/2020/11/Exten-secondary-lightblue-1-300x83.png)
EXTEN Technologies
Provider of high performance based storage software for real-time, big data, cloud, HPC, and other highly demanding data center applications.
View Website![](https://www.newscienceventures.com/wp-content/uploads/2020/11/Logo_Ferric.jpg)
Ferric Semiconductor, Inc.
Focused on creating single chip switching voltage regulators that are small, fast and efficient.
View Website![](https://www.newscienceventures.com/wp-content/uploads/2020/11/flowcardiawhite.png)
FlowCardia
Acquired by C.R. Bard. Developer of endovascular devices for the treatment of coronary and peripheral CTO.
![](https://www.newscienceventures.com/wp-content/uploads/2023/05/GW-blk-primary-300x138.png)
Glydways
A new on demand, anytime, high capacity mobility system.
View Website![](https://www.newscienceventures.com/wp-content/uploads/2020/11/Logo_GTxcel.jpg)
GTxcel, Inc.
Developer of a proprietary publishing platform that offers a comprehensive digital, web, and mobile publishing solution.
View Website![](https://www.newscienceventures.com/wp-content/uploads/2020/11/icadwhite.png)
iCAD
Provider of cancer detection and radiation therapy solutions.
View Website![](https://www.newscienceventures.com/wp-content/uploads/2017/10/InterLinkAI-Logo-pahyepxc72glzuiwndbjj1hajwop89mphpn75i9knu-300x55.png)
INTERlink AI
Provider of an automated solution for pharmacy pill-dispensing.
View Website![](https://www.newscienceventures.com/wp-content/uploads/2020/11/k2mwhite.png)
K2M
Acquired by Welsh, Carson, Anderson & Stowe. Developer of solutions for the treatment of complex spinal pathologies.
![](https://www.newscienceventures.com/wp-content/uploads/2020/11/Logo_Kateeva.jpg)
Kateeva, Inc.
Supplier of an innovative inkjet-based printing solution to enable printing of large-format organic light-emitting diodes (OLEDs) on a mass-production basis.
View Website![](https://www.newscienceventures.com/wp-content/uploads/2020/11/lightwirewhite.png)
Lightwire
Acquired by Cisco. Developer of advanced optical interconnect technology for high-speed networking applications.
![](https://www.newscienceventures.com/wp-content/uploads/2020/11/Logo_m-300x98.jpg)
Morrow
Focused on the commercialization of spectacles with digital lens technology.
View Website![](https://www.newscienceventures.com/wp-content/uploads/2020/11/Logo_NorthSea-300x111.png)
NorthSea Therapeutics
Focused on the development of first-in-class therapeutics for NASH and other metabolic, inflammatory and fibrotic diseases.
View Website![](https://www.newscienceventures.com/wp-content/uploads/2020/11/Novadip-300x99.png)
Novadip
Focused on the development of therapies for hard and soft tissue reconstruction from autologous adipose stem cells.
View Website![](https://www.newscienceventures.com/wp-content/uploads/2020/11/ovizio16680.jpg)
Ovizio Imaging Systems
Provider of digital holographic microscopy technology.
View Website![](https://www.newscienceventures.com/wp-content/uploads/2020/11/oxyranewhite51.png)
Oxyrane
Focused on the development of next-generation enzyme replacement therapies for lysosomal storage diseases based on a yeast-based platform.
View Website![](https://www.newscienceventures.com/wp-content/uploads/2021/08/Pakal-logo.png)
Pakal Technologies
Global leader in advanced silicon-based power semiconductors
View Website![](https://www.newscienceventures.com/wp-content/uploads/2020/11/PCDx-300x75.png)
Paradigm Diagnostics
Acquired by Exact Sciences. Provider of a molecular diagnostic test to guide clinical decision making for cancer patients.
View WebsiteParagraf
Global leader of graphene-based electronics technologies and products
View Website![](https://www.newscienceventures.com/wp-content/uploads/2021/06/PhaseFour-logo-300x59.png)
Phase Four
Creator of the radio-frequency thruster for satellite propulsion.
View Website![](https://www.newscienceventures.com/wp-content/uploads/2020/11/Picture1.png)
PlanetIQ
Focused on generating higher quality atmospheric data through the design of a new satellite-deployed instrument.
View Website![](https://www.newscienceventures.com/wp-content/uploads/2022/11/Resolve-logo-resolve-180.png)
Resolve Therapeutics
Focused on the development of a biologic therapy for Lupus and Sjögren’s Syndrome.
View Website![](https://www.newscienceventures.com/wp-content/uploads/2020/11/seahorsewhite.png)
Seahorse Bioscience
Acquired by Agilent Technologies. Developer of tools for measuring cell metabolism.
![](https://www.newscienceventures.com/wp-content/uploads/2020/11/sensorplatformswhite-1.png)
Sensor Platforms
Acquired by Audience. Developer of algorithms and software enabling consumer applications to better understand user contexts and intent.
![](https://www.newscienceventures.com/wp-content/uploads/2020/11/theroxwhite84.png)
Therox
Acquired by Zoll Medical. Developer of SuperSaturated Oxygen (SSO2) therapy to complement percutaneous coronary intervention.
![](https://www.newscienceventures.com/wp-content/uploads/2020/11/tigerconnect.png)
TigerConnect
Provider of a texting solution that is easy to use, flexible, easy to learn, and HIPAA (Health Insurance Portability and Accountability Act of 1996) compliant.
View Website![](https://www.newscienceventures.com/wp-content/uploads/2020/11/trelliswhite.png)
Trellis Bioscience
Developer of CellSpot platform to derive therapeutic antibodies directly from the human immune system.
View Website![](https://www.newscienceventures.com/wp-content/uploads/2020/11/vt98.jpg)
Vascular Therapies
Focused on the development of a drug-based solution to reduce the failure rate of AV Fistulas in dialysis patients.
View Website![](https://www.newscienceventures.com/wp-content/uploads/2020/11/logo_vaultive.png)
Vaultive
Acquired by CyberArk. Provider of encryption-in-use technology which enables businesses to encrypt their data before it goes to the cloud.
![](https://www.newscienceventures.com/wp-content/uploads/2020/11/VentyxBio-RGB-Web-300x85.png)
Ventyx Biosciences
Building a world-class immunology company.
View Website![](https://www.newscienceventures.com/wp-content/uploads/2020/11/vorago_1.png)
Vorago Technologies, Inc.
Provider of a patent-protected, process-based approach to harden semiconductor devices against radiation and thermal damage.
View Website![](https://www.newscienceventures.com/wp-content/uploads/2020/11/vuv-analytics.png)
VUV Analytics, Inc.
Analytical instrumentation company focused on exploiting the vacuum UV band of the spectrum.
View Website![](https://www.newscienceventures.com/wp-content/uploads/2017/10/Zeotap-new.png)
zeotap GmbH
Developer of a platform to allow telco operators to monetize their data securely and at scale.
View Website